| Literature DB >> 35914835 |
Wei Yang1, Hairong Wei1, Gloria A Benavides2, William J Turbitt1, Jessica A Buckley1, Xiaosen Ouyang2, Lianna Zhou1, Jianhua Zhang2, Laurie E Harrington1, Victor M Darley-Usmar2, Hongwei Qin3, Etty N Benveniste3.
Abstract
Protein kinase CK2 is a serine/threonine kinase composed of two catalytic subunits (CK2α and/or CK2α') and two regulatory subunits (CK2β). CK2 promotes cancer progression by activating the NF-κB, PI3K/AKT/mTOR, and JAK/STAT pathways, and also is critical for immune cell development and function. The potential involvement of CK2 in CD8+ T cell function has not been explored. We demonstrate that CK2 protein levels and kinase activity are enhanced upon mouse CD8+ T cell activation. CK2α deficiency results in impaired CD8+ T cell activation and proliferation upon TCR stimulation. Furthermore, CK2α is involved in CD8+ T cell metabolic reprogramming through regulating the AKT/mTOR pathway. Lastly, using a mouse Listeria monocytogenes infection model, we demonstrate that CK2α is required for CD8+ T cell expansion, maintenance, and effector function in both primary and memory immune responses. Collectively, our study implicates CK2α as an important regulator of mouse CD8+ T cell activation, metabolic reprogramming, and differentiation both in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35914835 PMCID: PMC9492634 DOI: 10.4049/jimmunol.2101080
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.426